{
    "clinical_study": {
        "@rank": "154840", 
        "acronym": "SHIPP", 
        "arm_group": {
            "arm_group_label": "Persons prescribed PrEP", 
            "description": "adults prescribed daily oral antiretroviral preexposure prophylaxis (PrEP) with the coformulated TDF/FTC  to reduce HIV acquisition."
        }, 
        "biospec_descr": {
            "textblock": "Dried blood spots"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "A health services implementation pilot study, conducted with an observational cohort of\n      HIV-uninfected persons including men who have sex with men,  heterosexual women and men, and\n      injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at\n      four federally qualified health centers that provide sexual health and primary care services\n      to communities with high HIV incidence/prevalence."
        }, 
        "brief_title": "Sustainable Healthcenter Implementation PrEP Pilot Study", 
        "completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "HIV Chemoprophylaxis", 
            "HIV Preexposure Prophylaxis"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult\n\n          -  documented without HIV infection (acute or established)\n\n          -  report sexual behaviors that indicate substantial risk of HIV acquisition\n\n          -  report injection-related behaviors that indicate substantial risk of HIV acquisition\n\n        Exclusion Criteria:\n\n          -  <18 years of age\n\n          -  documented HIV infection (acute or established)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "1200 adult men who have sex with men, injection drug users, and heterosexually-active men\n        and women who are at substantial risk of acquiring HIV infection and initiate the use of\n        daily oral antiretroviral preexposure prophylaxis (PrEP) with TDF/FTC"
            }
        }, 
        "enrollment": {
            "#text": "1200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02074891", 
            "org_study_id": "CDC-NCHHSTP-6511"
        }, 
        "intervention": {
            "arm_group_label": "Persons prescribed PrEP", 
            "description": "Daily oral dose of coformulated TDF/FTC", 
            "intervention_name": "coformulated TDF/FTC", 
            "intervention_type": "Drug", 
            "other_name": [
                "Truvada", 
                "Tenofovir disoproxil fumarate (TDF)", 
                "Emtracitabine (FTC)"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Tenofovir disoproxil", 
                "Tenofovir"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "preexposure prophylaxis", 
            "PrEP", 
            "HIV"
        ], 
        "lastchanged_date": "March 22, 2014", 
        "link": {
            "description": "Link to CDC information about preexposure prophylaxis", 
            "url": "http://www.cdc.gov/hiv/prevention/research/prep/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "mickey.eder@accesscommunityhealth.net", 
                    "last_name": "Milton (Mickey) Eder, PhD", 
                    "phone": "312-526-2116"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60609"
                    }, 
                    "name": "Access Community Health Network - Grand Boulevard Health and Specialty Center"
                }, 
                "investigator": {
                    "last_name": "Milton (Mickey) Eder, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Aemuwa@nchcfqhc.org", 
                    "last_name": "Ada Emuwa, MD, MPH", 
                    "phone": "973-565-0355"
                }, 
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07114"
                    }, 
                    "name": "Newark Community Health Centers - Ludlow St. Clinic"
                }, 
                "investigator": {
                    "last_name": "Ada Emuwa, MD, MPH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hkwakwa@aol.com", 
                    "last_name": "Helena Kwakwa, MD, MPH", 
                    "phone": "215-685-6769"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19132"
                    }, 
                    "name": "Strawberry Mansion Health Center"
                }, 
                "investigator": {
                    "last_name": "Helena Kwakwa, MD, MPH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sadeniran@centralcarechc.org", 
                    "last_name": "Sumbo Adeniran, MHA", 
                    "phone": "832-308-1084"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77033"
                    }, 
                    "name": "Central Care Community Health Centers - MLK Boulevard Clinic"
                }, 
                "investigator": {
                    "last_name": "Sumbo Adeniran, MHA", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Sustainable Healthcenter Implementation PrEP Pilot Study", 
        "overall_contact": {
            "email": "dsmith1@cdc.gov", 
            "last_name": "Dawn K Smith, MD, MS, MPH", 
            "phone": "404-639-5166"
        }, 
        "overall_official": [
            {
                "affiliation": "Centers for Disease Control and Prevention", 
                "last_name": "Dawn K Smith, MD, MS, MPH", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "CDC Foundation", 
                "last_name": "Rebecca Hartz, MPH", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Side effects, rates of renal adverse events, rates of atraumatic bone fractures, HIV infections with/without virus with mutations associated with TDF or FTC resistance, documented at clinical visits while prescribed PrEP", 
                "measure": "Clinical safety", 
                "safety_issue": "Yes", 
                "time_frame": "Every 3 months up to 36 months"
            }, 
            {
                "description": "Self-reported medication adherence and detection of tenofovir in dried blood spots at each clinical visit while prescribed PrEP", 
                "measure": "Medication adherence", 
                "safety_issue": "Yes", 
                "time_frame": "Every 3 months up to 36 months"
            }, 
            {
                "description": "Trends in sexual and injection HIV acquisition risk behaviors among patients  measured at each clinic visit while prescribed PrEP", 
                "measure": "Behavioral Responses", 
                "safety_issue": "Yes", 
                "time_frame": "Every 3 months up to 36 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02074891"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centers for Disease Control and Prevention", 
            "investigator_full_name": "Dawn Smith", 
            "investigator_title": "Biomedical Interventions Activity Lead, Epidemiology Branch, DHAP, NCHHSTP", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Source of payment, cost, and reimbusement for medication and clinical care associated with each clinical visit for PrEP", 
                "measure": "Costs", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 years"
            }, 
            {
                "description": "Variation in clinical practices at each clinic visit for PrEP-related care relative to PHS PrEP guidelines, and the relationship of clinical practices to patient outcomes", 
                "measure": "Clinical practice variation", 
                "safety_issue": "No", 
                "time_frame": "Every 3 months up to 36 months"
            }
        ], 
        "source": "Centers for Disease Control and Prevention", 
        "sponsors": {
            "collaborator": {
                "agency": "Gilead Sciences", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "CDC Foundation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}